Li Jihua, He Jun, Zhang Yunsheng, Huang Yunchao, Liu Shi'an, Li Yun, Xu Jun, He Xingzhou, Lan Qing
Qujing Centers for Disease Control and Prevention, Qujing 655000, China.
Yunnan Cancer Hospital, Kunming 650118, China.
Zhongguo Fei Ai Za Zhi. 2019 Aug 20;22(8):477-487. doi: 10.3779/j.issn.1009-3419.2019.08.01.
Lung cancer rates among women in rural Xuanwei and Fuyuan counties in eastern Yunnan province, China, are among the highest in the world, even though almost all women are non-smokers, and they tend to develop lung cancer at a younger age than other locations by roughly 5 yr-10 yr. This study investigated the survival of lung cancer patients among female never-smokers.
The female never-smokers, who had lived for many years in Xuanwei and Fuyuan counties, with lung cancer newly-diagnosed between July 2006 to March 2010, were followed up through the end of 2016. Age-standardized relative survival for all cases was calculated using local life table. The Kaplan-Meier method and Log-rank test were used to analyze the relationship between the variables and the prognosis in univariate analysis. Cox regression analysis was employed in the multivariate analysis.
Among 1,250 total subjects, 1,075 died and the remaining 175 were censored during the follow-up, with a median follow-up period of 69 months (95%CI: 61.9-76.0). Overall, the mean age was (54.8 ±10.9) yr, with variable clinical stages: 3.5% of cases were stage I, 8.7% stage II, 20.7% stage III, 29.7% stage IV, and 37.4% stage unknown. The 645 patients(51.6%) with cyto-histological diagnosis contains 303 with Squamous cell carcinoma, and 231 with adenocarcinoma, 24 with small cell, 43 with other specified type and 39 with unknown histological type. Only 215 (17.2%) patients received surgery, 487 (39.0%) were treated without surgery, and 548 (43.8%) did not receive any specific anticancer therapy. The 5-year observed survival rate and age-standardized relative survival were 8.9% (95%CI: 7.0-10.6), and 10.1% (95%CI: 3.7-20.5) respectively, with a median survival of 13.2 months. The 5-year survival rates were 41.1% for stage I, 22.4% for stage II, 5.3% for stage III, 1.3% for stage IV, 11.2% for missing stage, 17.9% for adenocarcinoma, and 5.6% for squamous cell carcinoma respectively. Surgery significantly improved 5-year survival rate compared with non-surgery (34.8% vs 3.2%, P<0.001). The patients with non-treatment, aged 65 years and older, living in rural areas and farmer with low socioeconomic status had poorer survival, whereas the patients treated in provincial hospitals and chest X-ray screening had better survival. Cox multivariate analysis further showed that stage of tumor-node-metastasis (TNM), treatment status, hospital-level, and X-ray screening were factors correlated with survival.
Patients with lung cancer among female never-smokers in Xuanwei and Fuyuan experience poorer survival, because they are less likely to be diagnosed at early stage, as well as less likely to receive surgery and comprehensive treatment. Furthermore low socioeconomic status and poor health security are also responsible for the low survival.
中国云南省东部宣威和富源县农村女性的肺癌发病率位居世界前列,尽管几乎所有女性都不吸烟,且她们患肺癌的年龄比其他地区的女性要小大约5至10岁。本研究调查了从不吸烟的女性肺癌患者的生存情况。
对2006年7月至2010年3月期间在宣威和富源县新诊断为肺癌、且多年居住在当地的从不吸烟女性进行随访,直至2016年底。使用当地生命表计算所有病例的年龄标准化相对生存率。单因素分析采用Kaplan-Meier法和Log-rank检验分析变量与预后的关系。多因素分析采用Cox回归分析。
在1250名研究对象中,随访期间1075人死亡,175人失访,中位随访时间为69个月(95%CI:61.9 - 76.0)。总体而言,平均年龄为(54.8±10.9)岁,临床分期各异:I期占3.5%,II期占8.7%,III期占20.7%,IV期占29.7%,分期不明占37.4%。645例(51.6%)经细胞组织学诊断的患者中,303例为鳞状细胞癌,231例为腺癌,24例为小细胞癌,43例为其他特定类型,39例组织学类型不明。仅215例(17.2%)患者接受了手术,487例(39.0%)未接受手术治疗,548例(43.8%)未接受任何特定的抗癌治疗。5年观察生存率和年龄标准化相对生存率分别为8.9%(95%CI:7.0 - 10.6)和10.1%(95%CI:3.7 - 20.5),中位生存期为13.2个月。I期、II期、III期、IV期、分期不明、腺癌、鳞状细胞癌的5年生存率分别为41.1%、22.4%、5.3%、1.3%、11.2%、17.9%和5.6%。与未手术相比,手术显著提高了5年生存率(34.8%对3.2%,P<0.001)。未接受治疗、年龄65岁及以上、居住在农村且社会经济地位低的农民生存较差,而在省级医院接受治疗和进行胸部X线筛查的患者生存较好。Cox多因素分析进一步表明,肿瘤-淋巴结-转移(TNM)分期、治疗状况、医院级别和X线筛查是与生存相关的因素。
宣威和富源从不吸烟的女性肺癌患者生存较差,原因是她们早期诊断的可能性较小,接受手术和综合治疗的可能性也较小。此外,社会经济地位低和医疗保障差也是生存率低的原因。